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Abstract RNA fragments containing the complete R region and 
the beginning of the U5 region ('R') from the human T cell 
leukaemia virus 1 (HTLV-1) stimulated the translation of the 
second eistrons in bicistronic mRNAs. The 5' untranslated region 
from SV40 early genes (SU) which was unable to stimulate 
translation of second cistrons amplified markedly the internal 
ribosome entry site (IRES) effect of the HTLV-1 'R' fragments. 
The 'R' regions from HTLV-1 have therefore properties imilar 
to internal ribosome entry sites (IRES) originally found in 
picornavirus. The beginning of the U5 region from HTLV-1 
contains a polypyrimidine sequence which is known to play an 
essential role in the IRES activity in picornavirus. The same 
experiments carried out using the 'R' region from bovine 
leukaemia virus (BLV) showed that this sequence has at most a 
weak IRES effect. One retroviruses HTLV-1 and perhaps others 
contain therefore an IRES activity. Interestingly, the combined 
SU 'R' sequence worked efficiently with different cistrons, 
different promoters and in all tested cell lines, whereas the 
poliovirus IRES was active in CHO cells but not in the mouse 
mammary cell line HCl l .  The SU 'R' sequence may therefore 
preferably be used to generate active bicistronic mRNAs. 
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I. Introduction 
The initiator of mRNA translation is a complex process 
involving the cap structure located in the 5'P end of the 
mRNA. A complex containing the 40S ribosome subunit 
and translation factors are formed at the cap level [1]. This 
complex migrates along the 5' untranslated region (5'UTR), 
according to a scanning mechanism, until it meets an initiator 
codon preceded by the consensus equence defined by M. 
Kozak [2]. In agreement with this model, it has been shown 
that the translation efficiency is greatly reduced when the 
5'UTR contains a secondary structure [3]. This rule is, how- 
ever, not respected in all cases. Indeed, in previous work, we 
observed that a combination of the SV40 early gene 5'UTR 
(SU) and the R region with the first 39 nucleotides of U5 
(designated as 'R') from the human T cell leukaemia virus 1 
(HTLV-1) markedly stimulates translation although it is 
highly structured (Attal et al., unpublished results). Another 
*Corresponding author. Fax: (33) 1-34-65-22-41 
0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. 
PH S00 1 4- 5793(96)008 15-0 
well-known exception is the case of picornavirus. The mRNA 
from these viruses have long and highly structured 5'UTRs 
which work efficiently in a cap-independent manner [4]. This 
concept is based on several experimental facts. The mRNA 
devoid of cap structure can be translated efficiently in a cell- 
free system when they contain in their 5'P end a picornavirus 
5'UTR. In vitro and in vivo, the mRNAs having an hairpin 
loop in their 5'P end can be translated efficiently if they have 
a picornavirus 5'UTR. In cells infected by poliovirus, the viral 
proteinase 2A which inactivates eIF4G does not prevent 
translation of an mRNA which contains a picornavirus 
5'UTR. It is generally admitted that the picornavirus 5'UTRs 
are able to bind directly ribosomes in a cap-independent man- 
ner and without a previous canning along the mRNA. Spe- 
cific protein factors are involved in this process and a poly- 
pyrimidine located in the 3'OH end of the picornavirus 
5'UTRs is required [5]. The picornavirus 5'UTRs are there- 
fore considered as containing an internal ribosome ntry site 
(IRES). 
In higher eucaryotes, most of the mRNAs are monocistro- 
nic. When a second cistron is added at the end of an mRNA, 
it is generally very poorly translated. However, in optimized 
conditions, the second cistron can be translated efficiently [6]. 
Interestingly, the addition of picornavirus IRES between two 
cistrons greatly stimulates the translation of the second [7]. 
This property is considered as an additional proof that picor- 
navirus 5'UTRs contain functional IRES. 
RNA sequences having IRES properties has been found in 
number of viruses including most, if not all, the members of 
the picornavirus family [8], in hepatitis C [9], murine hepatitis 
virus [10], pestivirus [11], Moloney mouse leukaemia virus [12] 
and Friend mouse leukaemia virus [13]. These structures have 
a more or less similar mechanism of action [14,15]. Interest- 
ingly, RNA sequences with IRES activity have also been 
found in several cellular mRNAs including those coding for 
the immunoglobulin heavy chain binding protein (BIP) [16], 
the antennapedia [17] and the [3 chain of kinesin [18]. All these 
sequences are considered to remain active when cells are 
stressed and when the translation factors cannot use any 
more the cap [19,20]. 
All the IRES seem to have in common the fact that they are 
highly structured. In a previous tudy, we observed that the R 
region from HTLV-1 and to a lower degree from BLV stimu- 
late mRNA translation although they are highly structured. 
The effect of R from HTLV-1 was greatly amplified by the 
SV40 early gene 5'UTR (SU) (Attal et al., unpublished re- 
suits). The present work has been undertaken to determine 
if R regions from both retroviruses associated or not to the 
5'UTR from SV40 have an IRES activity. 
All rights reserved. 
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2. Materials and methods 
2.1. Gene constructions 
Three promoters have been used: the rabbit whey acidic gene up- 
stream (WAP) region which is active in mammary cells, a combina- 
tion of SV40 enhancer and human cytomegalovirus (CMV) promoter 
and the Rous sarcoma virus (RSV) promoter which work in most cell 
types. These regulatory regions have been used and described in our 
previous tudies (Attal et al., unpublished results, [21]). 
The 'R' region from HTLV-1 was the 267 bp DNA fragment de- 
fined by Takebe et al. [22]. It contains the whole R and a 39 nucleo- 
tides of U5 region. 
The BLV R region was the a 250 bp Hae III fragment which con- 
tained only the R part of the viral genome minus a few nucleotides in
the 3'OH end. It was the generous gift of Dr. L. Willems. 
The poliovirus 5'UTR containing the IRES was kindly provided by 
Dr. N. Sonenberg. 
The SV40 early gene 5'UTR (SU) contained the 86 bp following the 
cap site. 
The human growth hormone (hGH) eDNA and the luciferase gene 
were used as the first cistron. The reporter genes were the bovine 
growth hormone (bGH) eDNA and the chloramphenicol acetyl trans- 
ferase gene. 
All constructs with WAP and CMV promoters contain the tran- 
scription terminator f om the SV40 late genes. 
The plasmid p245 was derived from pRSV luciferase plasmid [23] 
after cloning a sequence containing SU 'R' CAT (chloramphenicol 
acetyl transferase gene) between the stop codon of the luciferase 
gene and the transcription terminator f om the SV40 early genes. 
The plasmid p262 was constructed by introducing the synthetic 30 
mers oligodeoxynucleotide pAGCTTGGCCGGGCGCGGCCGCG- 
CCCGGCCA in the HindllI site between the RSV promoter and 
luciferase gene. This oligonucleotide is complementary to itself and 
two molecules can form a double-strand DNA for cloning. On the 
other hand, the coding strand generates a GC-rich stable hairpin loop. 
All these elements were associated using the classical method of 
genetic engineering. They were introduced in the plasmid pPoly III 
as described in our previous tudies (Attal et al., unpublished results, 
[21]).  
All the gene constructs used are described in Fig. 1. 
2.2. Cell transfection and protein measurements 
The mouse mammary cells HCl l  were transfected at mid-con- 
fluency using lipofectamine (BRL). The plasmid pRSV nee was added 
to the plasmids of interest containing the WAP gene promoter to 
obtain stable clones. The mixed clones were cultured to hypercon- 
fluency in the presence of fetal calf serum and EGF (10 ng/ml) and 
induced by insulin (5 Ixg/ml), dexamethasone (10 -~ M) and ovine 
prolactin (NIH-PS13) (5 gg/ml) for 2 days in the absence of EGF 
and serum as described previously (Attal et al., unpublished results, 
[21]). Culture medium were collected at the end of the induction and 
bGH was measured using a specific radioimmunoassay (Attal et al., 
unpublished results, [21]). 
CHO cells were transfected with the plasmids containing the CMV 
and RSV promoters using lipofectamine. Two days after transfection 
the medium was collected for bGH measurements, the CHO cells were 
scrapped for luciferase and CAT analysis. Luciferase activity was 
measured according technique published by De Wet et al. [23] in a 
Lumat LB9501 (Berthold, Wildbad, Germany). Cellular extracts were 
assayed for CAT activity using a mixed phase assay [24]. 
2.3. Northern blot analysis 
RNA isolation and Northern blot analysis were performed as pre- 
viously described [25]. 
3. Results 
The bicistronic mRNA containing only hGH and bGH 
cDNAs (p9') and the WAP gene promoter was poorly capable 
of translating the bGH cistron in HC l l  cells (Fig. 2). The 
addition of the R region from HTLV-1 (p202) enhanced quite 
significantly the translation of the bGH cistron. The R region 
from BLV (p203') showed a lower stimulatory effect. The 
p 14 l ~ J ~ ,  
p 9~ 
WAP 
p 14' J ' ~-- 
p 201' ~ 
WAP j~ 
p zoz' I 
p 205' 
WAP [-~ 
p204 '  I 
WAP F ~, 
p 2o~' I 
pl4L [ - " -~ ,  
WAP i-~ 
p 204L [ 
WAP r ~ 
p2OIL I 
pl3 [ " ~ ,  
CMV i~ 
p74 [ n 
p73 
CMV i ~ 
p75 I 
late SV 40 
VP t SU "R" bGH eDNA poly A 
I I V///'///////'///////AltlllilllltlllllllIIItllilllllll 
late SV40 
VP t hGH eDNA t)GHcDNA Ool~ A 
IN\\\ \ \ \~\\\ \ \ \ \ \ \~lr#'// / / / / / / / / / / / / /~l[ l l l l l l ]  IT[ l l ll l lllllllll 
late SV40 
VP I hGH eDNA SU "R" bGHcDNA poly A 
late 5V 40 
VP I hGH eDNA Pol io bGH eDNA Dolv A 
P.~\\\\\\\\\\\\\\\N~I I~/~///////////////JIl~l[Jllllri~lrlllllllflll/~r~l 
fate SV40 
VP I hGH eDNA "R" bGH eDNA polyA 
~\\\ \ \~\~.~\~\~N] l~'////'/////////////JllllllLllllllllIIIIllllllltllll I 
late SV40 
Vp I hGHcDNA SU bGH eDNA poly A 
t~\\\\\\\\\\\\\\\\\\',l g/////////////////Ailttlllllllllllttllllltllil[llfl 
late SV40 
VP I hGH eDNA SU BLV bGH eDNA pal}, A 
~-~\\ \ \ \~\\ \ \~\~\~ J r/////////////X///AI/lllliliJll[ll II[l lllJll m II 
late SV40 
VP I hGH eDNA BLV bGH eDNA polyA 
=%\\\ \ \ \ \ \ \ \ \ \ \ \ \ \ \N~I F/// / / / / / / / / / / / / / /AIJ l( I] l l l l l l J l ]  llfllflllflfJIII 
late SV40 
VP I Luc  SU "R" bGH eDNA pol~' A 
late 5V40 
VP I LUC SU et.V bGH eDNA pol¥ A 
::!i~:i:!~:i!!~ii~ ~i: ::i :~:~ia.~:~:i:i~i~:~:~ i! I W///'////////..~P'///lirtfllrllllllllllJl/rllrlillJll 
late SV4O 
VP I Luc Palia bGHeDNA polyA 
late SV40 
VP I I~UI  "R" bGHcDNA pol).A 
f~//'///////////////AIIII]llllllllllllllllllI[ll[llil 
lots SV40 
VPI hGH eDNA bGH eDNA pol~ A 
~\ \N 'c lF / / / / / / / / / / / / / / / / / / J l P l l l l l l / r l l f l l l l l l l l l T IP l r l l l l !  
late SV40 
VP I hGH eDNA SU "R" {~GH eDNA pol~A 
R~\\\ \ \ \ \ \ \ \ \ \ \ \ \ \~I  I I~/////////////~////AIIlllllllllllllllllJllllllllll 
late SV 40 
VP I hGHcDNA Polio bGH eDNA poly A 
:--N\\\\\\\\\\\\\\\\\~I r//////////////////ArRiiiliftrlllliilillrtflflrplrl 
early SV40 
RSV ~ Luc SU "R" C AT ~ A 
RSV i-~ loop LUC SU "R" CAT e°r~YolSyV40 
p 262 I I ~:i:]:i:i~;]~:;'::~:::~:::;~:::~:i:~:E:]:!:i:l I ~ l ig l l l f f i  IIHIIIIIIIIIllllllJllJJ] i 
Fig. 1. Schematic representation f the gene constructions. The dif- 
ferent elements are not on scale. WAP: rabbit whey acidic promo- 
ter; SU: SV40 early gene 5; UTR; bGH bovine growth hormone; 
eDNA hGH: human growth hormone eDNA; VPI: intron from 
the SV40 late genes; late SV40 polyA: transcription terminateur 
from SV40 late genes; R: the 267 bp from HTLV-1 containing the 
R region and 39 bp of U5; Polio: IRES from poliovirus; BLV: the 
R region minus a few nucleotides in the Y0H from the bovine leu- 
kaemia virus; CMV: human cyto-megalovirus promoter; SV40 en- 
hancer; Luc: firefly luciferase gene. 
SV40 early gene 5 'UTR (SU) was totally inactive alone 
(p205'). This RNA sequence markedly amplified the action 
of the R region from HTLV-1 (p14') but not from BLV 
(p204'). Interestingly, the combination SU 'R'  allowed trans- 
lation of the bGH cistron at a level as high as 70% of that 
obtained with monocistronic mRNA (p14). Surprisingly, the 
poliovirus IRES (p201') was almost completely inactive in 
these conditions. 
In order to determine if the IRES activity of the R regions 
from HTLV-1 and BLV was dependent on the nature of the 
first cistron, the hGH eDNA was replaced by the firefly luci- 
ferase gene. Results shown in Fig. 3 confirm that the SU 'R'  
and to a lower degree SU BLV associations were able to 
promote the translation of the bGH cistron. The poliovirus 
IRES showed only a very weak activity as in the case of the 
p201' construct. This lack of bGH synthesis was not due to 
the absence of the mRNA since the luciferase activity in the 
cellular extract was quite high (not shown). 
Unexpectedly, the bGH cistron preceded by the SU 'R'  
combination (pl4L) was translated at a level representing 
only 20% of the corresponding monocistronic mRNA (p14). 
This suggests that both cistrons work in a non-totally inde- 
pendent manner, even in the presence of the IRES. 
In order to determine if the cell type may favour more or 
less the activity of IRES, genes containing the hGH and the 
bGH cistrons, the hCMV promoter and the different IRES 
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Fig. 2. The IRES effect of the R region from HTLV-1 and BLV. 
Bicistronic onstructs containing the bGH and hGH cDNAs and 
the WAP gene promoter were use to generate stable HCll clone, 
bGH was measured in the medium after hormonal induction. The 
plasmids used are those depicted in Fig. 1. 
were constructed and transfected into CHO cells. Results 
shown in Fig. 4 indicate with no ambiguity that the bicistronic 
mRNA devoid of IRES (p74) was unable to translate the 
1 
bGH cistron. The SU 'R' IRES (p73) was quite efficient, 
leading to a bGH synthesis representing about 60% of the 
corresponding monocistronic mRNA (p13). The poliovirus 
IRES (p75) was of similar efficiency. 
The SU 'R' was also used in several other combinations of
cistrons (firefly luciferase, 13-galactosidase, chloramphenicol 
acetyl transferase, ...). It was quite efficient to express the 
second coding region in transfected cultured cells and in trans- 
genic mice and rabbits (not shown). 
In addition to bGH in the culture medium, a luciferase 
activity was found in the extracts from cells transfected with 
plasmids containing the corresponding cistron in the first po- 
sition. To make sure that the SU 'R' sequence between the 
two cistrons did not act as a cryptic promoter, CHO cells were 
transfected with plasmid p73. The RNA was extracted from 
the cells. Northern blot analysis using bGH and hGH cDNA 
as probes shown in Fig. 5 indicates with no ambiguity that a 
single mRNA containing 2.2 kb was obtained after transfec- 
tion with the plasmid p73. Moreover, experiments not shown 
here indicated that the SU 'R' sequence nhanced at most 
marginally the concentration f the corresponding mono and 
bicistronic mRNA in CHO cells. 
In previous tudies, it has been shown that in biscistronic 
mRNA containing an IRES, translation of the first cistron is 
severely reduced by the addition of a stable hairpin loop after 
the cap site whereas translation of the second cistron is not 
affected. The hairpin loop described in Section 2 was able to 
reduced the expression of monocistronic mRNA to 15-20% of 
the control (not shown). The same hairpin loop added in the 
plasmid p245 (Fig. 1) before the luciferase cistron (p262) at- 
tenuated quite significantly its expression but it did not mod- 
ify CAT activity (Fig. 6). One possible interpretation f these 
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Fig. 3. The IRES effect of the R regions from HTLV-1 and BLV in 
HC11 cells. The bicistronic onstructs contained the luciferase and 
the bGH cDNAs driven by the WAP gene promoter, bGH was 
measured in the medium after hormonal induction. 
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Fig. 4. The IRES effect of R regions from HTLV-1 and BLV in 
CHO cells. The gene constructs contained the hGH and bOH 
cDNAs driven by the hCMV promoter, bOH was measured in the 
medium 2days after transfection. 
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Fig. 5. Nothern blot analysis of the mRNA transcribed from the 
plasmid p73 transfected into CHO cells. Controls were non-trans- 
fected CHO cells (Fig. 1). Hybridizations were carried out using 
bGH and hGH cDNA probes. 
data is that ribosomes were recruited by the SU 'R'  sequence 
independently of the luciferase cistron. 
4. Discussion 
The data reported here leave little doubt on the fact that the 
R and the beginning of the U5 regions from HTLV-1 have the 
capacity to stimulate the translation of the second cistron in 
bicistronic mRNA. This adds to the list of the mRNAs having 
a 5 'UTR which allows initiation of translation without a cap 
in its vicinity. A sequence containing an IRES activity has 
been found recently in two other retroviruses, the Moloney 
mouse leukaemia virus [12] and the Friend mouse leukaemia 
virus [13]. Interestingly, however, in these two viruses, the 
IRES is located after the U5 region between two initiator 
codons. The function of the IRES seems then to favour the 
utilization of both initiator codon more or less independently. 
In the case of HTLV-1, the IRES is in the 'R'  region. The 
included short part of the U5 might be important for the 
IRES function. One reason inclines to think that this is indeed 
the case. In picornavirus, the end of the IRES section contains 
a polypyrimidine region with the consensus equence UUUC 
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Fig. 6. The effect of a hairpin loop on the translation of the cistrons 
of a bicistronic mRNA containing the SU 'R' sequence. Plasmids 
p245 and p262 (Fig. 1) were transfected into CHO cells. Luciferase 
and CAT activities were measured in cell extracts. Results are the 
means + SEM of three independent transfections. 
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Fig. 7. Nucleotide sequence of the U5 region from HTLV-1 present 
in the gene constructs. The polypyrimidine r gions are overlined, 
with two lines for the consensus sequence binding proteins. 
or UUC [5,8]. It is noteworthy that such a polypyrimidine 
region was found in the Moloney mouse leukaemia virus 
[12] but also in the U5 part of the HTLV-1 sequences used 
in the present experiments (Fig. 7). The beginning of the U5 
region of the BLV also contains a polypyrimidine sequence 
which might participate to the IRES activity [26]. This U5 
region was not present in the BLV fragment used in the pre- 
sent experiment. This might explain why the R region from 
BLV showed a lower IRES activity than that from HTLV-1 
(Figs. 2 and 3). 
The exact role of the 5 'UTR from SV40 is not known. In a 
previous study, we observed that this 5 'UTR is highly struc- 
tured and that it does not alter the secondary structure of the 
HTLV-1 'R'  region when associated to it (Attal et al., unpub- 
lished results, [21]). 
From a practical point of view, the IRES formed by the 
association of SU and 'R'  from HTLV-1 described here offers 
several advantages to generate fficient bicistronic mRNAs. 
Indeed, the poliovirus IRES is not active in all cell type and 
its effect is maximum only in poliovirus infected cells. The 
encephalomyocarditis virus IRES seems less sensitive to the 
cell type used, but the AUG which is recognized as the in- 
itiator must be located in a precise position, a property which 
complicates gene construction. The new SU 'R'  IRES de- 
scribed here is therefore highly flexible and efficient. For these 
reasons it may be preferred to others. 
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